The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Salmon, R. A.
Right arrow Articles by Schrader, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Salmon, R. A.
Right arrow Articles by Schrader, J. W.

The Journal of Immunology, Vol 159, Issue 11 5309-5317, Copyright © 1997 by American Association of Immunologists


ARTICLES

The p38 mitogen-activated protein kinase is activated by ligation of the T or B lymphocyte antigen receptors, Fas or CD40, but suppression of kinase activity does not inhibit apoptosis induced by antigen receptors

RA Salmon, IN Foltz, PR Young and JW Schrader
The Biomedical Research Centre, University of British Columbia, Vancouver, Canada.

We have investigated the activation of the p38 mitogen-activated protein kinase (MAPK) in normal mouse T and B cells and its role in apoptosis. Cross-linking of the CD3 chains of the TCR complex on proliferating T cells resulted in activation of p38 MAPK and MAPKAP kinase-2. Cross-linking of CD28 failed to activate p38 MAPK or MAPKAP kinase-2, but synergized strongly with low doses of anti-CD3. Cross- linking of Fas on T cells also induced rapid activation of p38 MAPK and MAPKAP kinase-2. The in vivo activation of MAPKAP kinase-2 in response to cross-linking of CD3, Fas, or CD3 and CD28 was shown to be dependent on p38 MAPK activity using a specific inhibitor, SB 203580. SB 203580 did not inhibit activation-induced cell death in T cells when used at concentrations that suppressed activation of MAPKAP kinase-2 in vivo. Cross-linking of the B cell Ag receptor (BCR) or CD40 on freshly isolated or LPS-activated splenic B cells or the immature B lymphoma, WEHI 231, resulted in activation of p38 MAPK and MAPKAP kinase-2. In vivo inhibition of p38 MAPK activity in WEHI 231 cells by SB 203580 had no effect on either BCR-induced apoptosis or anti-CD40-mediated suppression of apoptosis. We conclude that the activation of p38 MAPK and MAPKAP kinase-2 by cross-linking of the TCR, BCR, Fas, or CD40 was not correlated with their roles in regulating lymphocyte survival, and that suppression of kinase activity did not inhibit the induction of apoptosis.


This article has been cited by other articles:


Home page
J. Immunol.Home page
J. K. Lee, S. O. Mathew, S. V. Vaidya, P. R. Kumaresan, and P. A. Mathew
CS1 (CRACC, CD319) Induces Proliferation and Autocrine Cytokine Expression on Human B Lymphocytes
J. Immunol., October 1, 2007; 179(7): 4672 - 4678.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Maneechotesuwan, Y. Xin, K. Ito, E. Jazrawi, K.-Y. Lee, O. S. Usmani, P. J. Barnes, and I. M. Adcock
Regulation of Th2 Cytokine Genes by p38 MAPK-Mediated Phosphorylation of GATA-3
J. Immunol., February 15, 2007; 178(4): 2491 - 2498.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
N. Farley, G. Pedraza-Alva, D. Serrano-Gomez, V. Nagaleekar, A. Aronshtam, T. Krahl, T. Thornton, and M. Rincon
p38 Mitogen-Activated Protein Kinase Mediates the Fas-Induced Mitochondrial Death Pathway in CD8+ T Cells.
Mol. Cell. Biol., March 1, 2006; 26(6): 2118 - 2129.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
N. Niederberger, L. K. Buehler, J. Ampudia, and N. R. J. Gascoigne
Thymocyte stimulation by anti-TCR-{beta}, but not by anti-TCR-{alpha}, leads to induction of developmental transcription program
J. Leukoc. Biol., May 1, 2005; 77(5): 830 - 841.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Zhu, O. Granillo, R. Wen, K. Yang, X. Dai, D. Wang, and W. Zhang
Negative Regulation of Lymphocyte Activation by the Adaptor Protein LAX
J. Immunol., May 1, 2005; 174(9): 5612 - 5619.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. Basso, U. Klein, H. Niu, G. A. Stolovitzky, Y. Tu, A. Califano, G. Cattoretti, and R. Dalla-Favera
Tracking CD40 signaling during germinal center development
Blood, December 15, 2004; 104(13): 4088 - 4096.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. Y. Kim and H.-S. Teh
Critical Role of TNF Receptor Type-2 (p75) as a Costimulator for IL-2 Induction and T Cell Survival: A Functional Link to CD28
J. Immunol., October 1, 2004; 173(7): 4500 - 4509.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Guo, R. E. Gerl, and J. W. Schrader
Defining the Involvement of p38{alpha} MAPK in the Production of Anti- and Proinflammatory Cytokines Using an SB 203580-resistant Form of the Kinase
J. Biol. Chem., June 13, 2003; 278(25): 22237 - 22242.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S.-C. Hsu, C.-C. Wu, J. Han, and M.-Z. Lai
Involvement of p38 mitogen-activated protein kinase in different stages of thymocyte development
Blood, February 1, 2003; 101(3): 970 - 976.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
Z. Guo, G. Clydesdale, J. Cheng, K. Kim, L. Gan, D. J. McConkey, S. E. Ullrich, Y. Zhuang, and B. Su
Disruption of Mekk2 in Mice Reveals an Unexpected Role for MEKK2 in Modulating T-Cell Receptor Signal Transduction
Mol. Cell. Biol., August 15, 2002; 22(16): 5761 - 5768.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S. I. Gringhuis, E. A. M. Papendrecht-van der Voort, A. Leow, E. W. N. Levarht, F. C. Breedveld, and C. L. Verweij
Effect of Redox Balance Alterations on Cellular Localization of LAT and Downstream T-Cell Receptor Signaling Pathways
Mol. Cell. Biol., January 15, 2002; 22(2): 400 - 411.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
H. Yu, D. Leitenberg, B. Li, and R. A. Flavell
Deficiency of Small GTPase Rac2 Affects T Cell Activation
J. Exp. Med., September 24, 2001; 194(7): 915 - 926.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
W. Li, C. D. Whaley, J. L. Bonnevier, A. Mondino, M. E. Martin, K. M. Aagaard-Tillery, and D. L. Mueller
CD28 Signaling Augments Elk-1-Dependent Transcription at the c-fos Gene During Antigen Stimulation
J. Immunol., July 15, 2001; 167(2): 827 - 835.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Skapenko, P. E. Lipsky, H.-G. Kraetsch, J. R. Kalden, and H. Schulze-Koops
Antigen-Independent Th2 Cell Differentiation by Stimulation of CD28: Regulation Via IL-4 Gene Expression and Mitogen-Activated Protein Kinase Activation
J. Immunol., April 1, 2001; 166(7): 4283 - 4292.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. D. Richards, S. H. Dave, C.-H. G. Chou, A. A. Mamchak, and A. L. DeFranco
Inhibition of the MEK/ERK Signaling Pathway Blocks a Subset of B Cell Responses to Antigen
J. Immunol., March 15, 2001; 166(6): 3855 - 3864.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
L. L. Pearson, B. E. Castle, and M. R. Kehry
CD40-mediated signaling in monocytic cells: up-regulation of tumor necrosis factor receptor-associated factor mRNAs and activation of mitogen-activated protein kinase signaling pathways
Int. Immunol., March 1, 2001; 13(3): 273 - 283.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F. Marti, A. Krause, N. H. Post, C. Lyddane, B. Dupont, M. Sadelain, and P. D. King
Negative-Feedback Regulation of CD28 Costimulation by a Novel Mitogen-Activated Protein Kinase Phosphatase, MKP6
J. Immunol., January 1, 2001; 166(1): 197 - 206.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. L. Cannons, Y. Choi, and T. H. Watts
Role of TNF Receptor-Associated Factor 2 and p38 Mitogen-Activated Protein Kinase Activation During 4-1BB-Dependent Immune Response
J. Immunol., December 1, 2000; 165(11): 6193 - 6204.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. A. Bishop, Y. Hsing, B. S. Hostager, S. V. Jalukar, L. M. Ramirez, and M. A. Tomai
Molecular Mechanisms of B Lymphocyte Activation by the Immune Response Modifier R-848
J. Immunol., November 15, 2000; 165(10): 5552 - 5557.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
W. MIKULITS, B. PRADET-BALADE, B. HABERMANN, H. BEUG, J. A. GARCIA-SANZ, and E. W. MÜLLNER
Isolation of translationally controlled mRNAs by differential screening
FASEB J, August 1, 2000; 14(11): 1641 - 1652.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
P. G. del Arco, S. Martinez-Martinez, J. L. Maldonado, I. Ortega-Perez, and J. M. Redondo
A Role for the p38 MAP Kinase Pathway in the Nuclear Shuttling of NFATp
J. Biol. Chem., April 28, 2000; 275(18): 13872 - 13878.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
T. Labuda, A. Sundstedt, and M. Dohlsten
Selective induction of p38 mitogen-activated protein kinase activity following A6H co-stimulation in primary human CD4+ T cells
Int. Immunol., March 1, 2000; 12(3): 253 - 261.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. M. Swart, D. M. Bergeron, and T. C. Chiles
Identification of a Membrane Ig-Induced p38 Mitogen-Activated Protein Kinase Module That Regulates cAMP Response Element Binding Protein Phosphorylation and Transcriptional Activation in CH31 B Cell Lymphomas
J. Immunol., March 1, 2000; 164(5): 2311 - 2319.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
E. Fernandez
Thymocyte development past the CD4+CD8+ stage requires an active p38 mitogen-activated protein kinase
Blood, February 15, 2000; 95(4): 1356 - 1361.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Mori, O. Kaminuma, K. Miyazawa, K. Ogawa, H. Okudaira, and K. Akiyama
p38 Mitogen-Activated Protein Kinase Regulates Human T Cell IL-5 Synthesis
J. Immunol., November 1, 1999; 163(9): 4763 - 4771.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S.-C. Hsu, M. A. Gavrilin, M.-H. Tsai, J. Han, and M.-Z. Lai
p38 Mitogen-activated Protein Kinase Is Involved in Fas Ligand Expression
J. Biol. Chem., September 3, 1999; 274(36): 25769 - 25776.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. H. Schafer, S. A. Wadsworth, L. Wang, and J. J. Siekierka
p38{alpha} Mitogen-Activated Protein Kinase Is Activated by CD28-Mediated Signaling and Is Required for IL-4 Production by Human CD4+CD45RO+ T Cells and Th2 Effector Cells
J. Immunol., June 15, 1999; 162(12): 7110 - 7119.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Jaworowski, N. J. Wilson, E. Christy, R. Byrne, and J. A. Hamilton
Roles of the Mitogen-activated Protein Kinase Family in Macrophage Responses to Colony Stimulating Factor-1 Addition and Withdrawal
J. Biol. Chem., May 21, 1999; 274(21): 15127 - 15133.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. S. Pullen, T. T. A. Dang, J. J. Crute, and M. R. Kehry
CD40 Signaling through Tumor Necrosis Factor Receptor-associated Factors (TRAFs). BINDING SITE SPECIFICITY AND ACTIVATION OF DOWNSTREAM PATHWAYS BY DISTINCT TRAFs
J. Biol. Chem., May 14, 1999; 274(20): 14246 - 14254.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Zhang, K. V. Salojin, J.-X. Gao, M. J. Cameron, I. Bergerot, and T. L. Delovitch
p38 Mitogen-Activated Protein Kinase Mediates Signal Integration of TCR/CD28 Costimulation in Primary Murine T Cells
J. Immunol., April 1, 1999; 162(7): 3819 - 3829.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. H. Schafer, L. Wang, S. A. Wadsworth, J. E. Davis, and J. J. Siekierka
T Cell Activation Signals Up-Regulate p38 Mitogen-Activated Protein Kinase Activity and Induce TNF-{alpha} Production in a Manner Distinct from LPS Activation of Monocytes
J. Immunol., January 15, 1999; 162(2): 659 - 668.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Craxton, G. Shu, J. D. Graves, J. Saklatvala, E. G. Krebs, and E. A. Clark
p38 MAPK Is Required for CD40-Induced Gene Expression and Proliferation in B Lymphocytes
J. Immunol., October 1, 1998; 161(7): 3225 - 3236.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. C. Grammer, J. L. Swantek, R. D. McFarland, Y. Miura, T. Geppert, and P. E. Lipsky
TNF Receptor-Associated Factor-3 Signaling Mediates Activation of p38 and Jun N-Terminal Kinase, Cytokine Secretion, and Ig Production Following Ligation of CD40 on Human B Cells
J. Immunol., August 1, 1998; 161(3): 1183 - 1193.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. N. Foltz, R. E. Gerl, J. S. Wieler, M. Luckach, R. A. Salmon, and J. W. Schrader
Human Mitogen-activated Protein Kinase Kinase 7 (MKK7) Is a Highly Conserved c-Jun N-terminal Kinase/Stress-activated Protein Kinase (JNK/SAPK) Activated by Environmental Stresses and Physiological Stimuli
J. Biol. Chem., April 10, 1998; 273(15): 9344 - 9351.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Alonso, M. Saxena, S. Williams, and T. Mustelin
Inhibitory Role for Dual Specificity Phosphatase VHR in T Cell Antigen Receptor and CD28-induced Erk and Jnk Activation
J. Biol. Chem., February 9, 2001; 276(7): 4766 - 4771.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. Ma, W. Lim, K. Gee, S. Aucoin, D. Nandan, M. Kozlowski, F. Diaz-Mitoma, and A. Kumar
The p38 Mitogen-activated Kinase Pathway Regulates the Human Interleukin-10 Promoter via the Activation of Sp1 Transcription Factor in Lipopolysaccharide-stimulated Human Macrophages
J. Biol. Chem., April 20, 2001; 276(17): 13664 - 13674.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Glassford, M. Holman, L. Banerji, E. Clayton, G. G. B. Klaus, M. Turner, and E. W.-F. Lam
Vav Is Required for Cyclin D2 Induction and Proliferation of Mouse B Lymphocytes Activated via the Antigen Receptor
J. Biol. Chem., October 26, 2001; 276(44): 41040 - 41048.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1997 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1997 by The American Association of Immunologists, Inc. All rights reserved.